WNK2 and melanoma: The hallmarks of melanoma include mutations in genes associated with the mitogen-activated protein kinase (MAPK) pathway or the over-activation of proteins, which result in increased tumor cell proliferation and invasive capabilities, as well as immunosuppression within the tumor microenvironment (TME).